GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival

Area of Science:

• Immunology
• Autoimmune Diseases
• Inflammation

Background:

• Granulocyte macrophage-colony stimulating factor (GM-CSF) is implicated in organ-specific autoimmune inflammatory diseases.
• Its precise roles in initiating and perpetuating autoimmune responses require further elucidation.
• Autoimmune myocarditis serves as a relevant model to study GM-CSF mechanisms in autoimmunity.

Purpose of the Study:

• To investigate the specific mechanisms by which GM-CSF contributes to autoimmune heart inflammation.
• To explore the role of GM-CSF in the context of cytokine networks (IL-1, IL-6, IL-23, IL-17) in myocarditis.
• To determine how GM-CSF influences immune cell populations, particularly Th17 cells, in vivo.

Main Methods:

• Utilized a mouse model of autoimmune myocarditis induced by immunization with heart myosin.
• Assessed the impact of GM-CSF on cytokine production (IL-6, IL-23) by dendritic cells.
• Investigated the generation and maintenance of antigen-specific CD4(+) T cells, focusing on Th17 cell differentiation and survival.

Main Results:

• Innate GM-CSF was found to be essential for IL-6 and IL-23 production by dendritic cells.
• GM-CSF critically regulated the generation of pathogenic Th17 cells in the autoimmune setting.
• Enhanced IL-6-dependent survival of antigen-specific CD4(+) T cells was observed due to GM-CSF activity.

Conclusions:

• GM-CSF plays a significant role in promoting the development and maintenance of Th17 cells in autoimmune conditions.
• GM-CSF exerts its effects through the regulation of IL-6 and IL-23 pathways.
• These findings highlight GM-CSF as a potential therapeutic target for autoimmune inflammatory diseases like myocarditis.